David Turkaly analyst JMP

Currently out of the existing stock ratings of David Turkaly, 115 are a BUY (97.46%), 1 are a SELL (0.85%), 2 are a HOLD (1.69%).

David Turkaly

Work Performance Price Targets & Ratings Chart

Analyst David Turkaly works at JMP with a stock forecast success ratio of 32.61% fulfilled within 193.78 days on average.

David Turkaly’s has documented 239 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on KIDS, Orthopediatrics Corp at 07-Mar-2024.

Wall Street Analyst David Turkaly

Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 1/8/2021. The price target of $15 was fulfilled within 11 days with a profit of $2.11 (16.37%) receiving and performance score of 14.88.

Average potential price target upside

APYX Apyx Medical AXGN Axogen HAE Haemonetics IART Integra LifeSciences Holdings KIDS Orthopediatrics Corp NVRO Nevro Corp SRGA Surgalign Holdings STE STERIS plc STIM Neuronetics TFX Teleflex orporated ZBH Zimmer Biomet Holdings SIBN Si-Bone FNA Paragon 28 ICAD icad inc NVTR Nuvectra TELA Tela Bio GMED Globus Medical LNTH Lantheus Holdings

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4.5

$3 (200.00%)

3

8 months 15 days ago

14/16 (87.5%)

$-0.55 (-10.89%)

297

Buy

9

$7.5 (500.00%)

6

10 months 11 days ago

2/3 (66.67%)

$2.05 (29.50%)

81

Hold

10

11 months 2 days ago

3/3 (100%)

$1.8 (21.95%)

243

Buy

17

$15.5 (1033.33%)

12

1 years 9 months 7 days ago

0/2 (0%)

$8.43 (98.37%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is David Turkaly is most bullish on?

Potential upside of $73.83 has been obtained for TFX (TELEFLEX ORPORATED)

Which stock is David Turkaly is most reserved on?

Potential downside of $10.55 has been obtained for TELA (TELA BIO)

What Year was the first public recommendation made by David Turkaly?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?